TuBerculosis Vaccine Initiative (TBVI)
TBVI is an independent non-profit organisation that facilitates the development of new vaccines to protect future generations against tuberculosis.
We financially support and bring expertise to an integrated network of over 50 universities, institutes and industries to develop more effective, safe vaccines that will be globally accessible and affordable. Research conducted by our mostly European based network has already resulted in promising vaccine discoveries.
New vaccines are urgently needed to stop tuberculosis. Every year almost 9 million new cases of this infectious disease are recorded. Every year around 1.5 million people die of TB, equaling one death every 22 seconds.
Summary in other languages: 
Personal stories about tuberculosis
What is it like to live with TB? Read some of these touching stories.
Why invest in TB?
Investing in TB vaccines has potentially huge returns on investment. Both in lives saved and in euros.
News 
- 26.Mar.13 | Global Scientific Experts...
- 20.Mar.13 | Vaccines, the SUSTAINABLE...
- 18.Mar.13 | Documentary: Tuberculosis: An...
- 04.Feb.13 | First result Phase IIb...
Events
- 29.May.13 | Nineth Elsinore meeting on...
- 06.Jun.13 | TRANSVAC workshop: “The...
- 08.Sep.13 | Biomarkers for Tuberculosis:...
- 25.Sep.13 | Mucosal Vaccines Adjuvants &...